Why diabetes is not a sugar problem

Type 2 diabetes is diagnosed by a sugar number - HbA1c or fasting glucose. So it is understandable that most people, and quite a few doctors, treat it as a sugar problem. Cut the rice. Skip the sweets. Take the metformin. Recheck in three months.

But blood sugar is not the disease. Blood sugar is the last thing to break. By the time your HbA1c crosses 6.5, your body has been telling a much longer story, often for ten to fifteen years. Insulin has been climbing. The liver has been silting up with fat. The gut has been drifting. Inflammation has been simmering. Cortisol has been overworked.

Treating the sugar number without addressing any of that is like lowering a fever without asking what the infection is. The number falls. The disease continues.

This article is the longer, less comforting version of the conversation we have with patients who arrive at our clinic after years of rising doses and falling confidence. If you have prediabetes, new Type 2 diabetes, or even a family history that keeps you awake, this is the frame we would want you to begin with.

The biology the sugar number hides

When a cell in your muscle or liver becomes resistant to insulin, your pancreas compensates by making more. Insulin levels climb. This can go on for years with a perfectly normal fasting glucose and a perfectly normal HbA1c. The person looks metabolically fine on a standard report and feels quietly unwell.

Eventually the pancreas tires. Insulin production falters. Now glucose rises. Now HbA1c is abnormal. Now you have "diabetes."

That diagnosis marks the moment the compensation failed. Not the moment the disease started. The disease started when insulin first had to work harder, often a decade earlier.

Five upstream drivers push the system toward that failure.

1. Insulin resistance

The single most important, least-measured lab in Indian metabolic practice. Fasting insulin above roughly 10 µIU/mL, or a HOMA-IR above 2, indicates that the pancreas is already compensating. At this stage you have a window - maybe a large one - in which the trajectory can still be changed. Very few patients are offered that window, because fasting insulin is almost never on the standard panel.

2. Fatty liver

Non-alcoholic fatty liver disease (NAFLD) is present in roughly half of Indian adults with Type 2 diabetes and in a strikingly large share of thin Indians. A fatty liver does not only store fat. It leaks glucose into the bloodstream even at night, and it disrupts the insulin signal system-wide. A person can eat "clean," exercise, avoid sugar, and still run high HbA1c because the liver is stuck in a producing-and-releasing pattern.

3. Gut dysbiosis

The gut microbiome is directly wired to insulin sensitivity through short-chain fatty acids, bile acid metabolism, and the gut barrier. A damaged gut - by antibiotics, ultra-processed food, chronic acidity, or stress - nudges metabolism toward insulin resistance. This is why patients with long histories of IBS, bloating, or recurrent antibiotic use develop metabolic disease earlier than their peers.

4. Chronic inflammation

Low-grade inflammation, visible on a simple hs-CRP test, actively interferes with insulin signalling. Inflammation comes from many sources: visceral fat, a leaky gut, poor sleep, untreated gum disease, chronic viral load, autoimmune tissues. You cannot out-diet chronic inflammation, and insulin resistance will keep returning until it is addressed.

5. Cortisol and circadian dysregulation

Short sleep, erratic sleep, unrelenting stress, and late-night screen use push cortisol in the wrong direction. High evening cortisol drives the liver to dump glucose overnight. This is the patient whose fasting sugar is stubbornly 120 while their post-meal readings are reasonable. It is a circadian problem, not a food problem.

Each of these drivers is measurable. Each is modifiable. None is in a typical diabetes review.

Why the standard approach stalls

The standard approach is: diagnose by HbA1c, prescribe metformin, counsel on diet, review in three months, escalate as needed. It is safe, cheap, scalable, and - for many patients - insufficient.

It stalls for three reasons.

First, it treats the output and not the driver. The pancreas is told to work harder through medication. The upstream system is untouched. So the dose climbs over time.

Second, it forces generic dietary advice on bodies that are not generic. A gut-compromised patient cannot tolerate the same "whole-grain, lots of dal" plan as a gut-intact one. An insulin-resistant thin patient needs a different fat and protein profile than an insulin-resistant obese patient. The standard script is roughly "eat less rice and walk more." It is rarely wrong and rarely sufficient.

Third, it declares success when the sugar number is in range. But sugar in range on escalating medication is not remission. It is a controlled disease. Remission is sugar in range with reducing medication, reducing insulin, reducing inflammation, reducing fatty liver. These are different outcomes.

Case study - Ramesh, 46, Pune

Ramesh came to us after eight years of Type 2 diabetes. HbA1c 8.2. He was on metformin 1 g twice daily and glimepiride 2 mg. His previous doctor had just added a third drug. He was not overweight - BMI 24. He described himself as disciplined. He walked every morning. He had given up rice two years earlier.

Standard labs: fasting glucose 168, HbA1c 8.2, lipids "borderline."

Our initial panel added what the standard workup had missed:

• Fasting insulin 22 µIU/mL (should be well under 10)
• HOMA-IR 9.1 (should be under 2)
• hs-CRP 4.6 (high inflammation)
• ALT 62 and AST 48 (fatty liver)
• Ultrasound: Grade 2 fatty liver
• Vitamin D 14 ng/mL, B12 190 pg/mL
• Gut: long history of untreated reflux, four courses of antibiotics in the previous year

His diabetes looked like a sugar problem. It was a fatty liver problem wrapped inside a gut and inflammation problem with a vitamin D deficiency pushing from below. Cutting more rice was never going to move it.

Over nine months, the protocol addressed the drivers, not just the sugar. The liver was detrained with a targeted food pattern - fewer refined carbohydrates, but crucially more protein, more unsaturated fat, and deliberate evening fasting. Gut repair: a defined elimination, probiotic seeding, and management of reflux without chronic PPIs. Inflammation: vitamin D and B12 repletion, omega-3, weight training twice a week, sleep moved earlier by ninety minutes.

At nine months: HbA1c 5.6, fasting glucose 94, fasting insulin 6, HOMA-IR 1.4, ALT 24, hs-CRP 0.9, ultrasound shows Grade 1 fatty liver trending toward clear. Glimepiride had been stopped at month four under medical supervision. Metformin had been halved.

His own words: "Nobody had ever looked at my liver."

Case study - Priya, 34, Bangalore

Priya was not diabetic. She was flagged prediabetic on a routine screen - HbA1c 5.9, fasting glucose 102. Her doctor told her to "watch it." A colleague referred her to us because her mother had been diabetic from thirty-eight.

She was thin. She ate home-cooked food. She slept six hours a night and worked in tech.

What the extended panel showed:

• Fasting insulin 19 µIU/mL (high)
• HOMA-IR 4.8 (high)
• Triglyceride/HDL ratio 3.4 (unhealthy)
• hs-CRP 2.2
• Vitamin D 18 ng/mL
• Cycle: irregular 35-45 day cycles, acne along jawline
• Ultrasound: Grade 1 fatty liver, polycystic-appearing ovaries

Priya was not prediabetic in the way her doctor framed it. She was in an advanced state of insulin resistance, with the liver and ovary already showing the downstream print of it. Left alone with vague "watch it" advice, she would have had Type 2 diabetes within five years, exactly like her mother. Her own clinical picture also explained the acne and cycle irregularity - a PCOS-spectrum presentation driven by the same insulin problem.

We did not need her sugar to be the focus. We needed her insulin to fall. A protein-forward plan, protected sleep (seven and a half hours, enforced), strength training three times a week, vitamin D to therapeutic levels, and inositol for the ovarian side.

At six months: fasting insulin 7, HOMA-IR 1.5, HbA1c 5.3, cycle 30 days, jawline clear, triglyceride/HDL 1.6. Her HbA1c number moved by 0.6, which sounds small. What moved under it was the disease.

Case study - Imran, 52, Mumbai

Imran had been diabetic for twelve years. Three drugs. HbA1c 7.9. Blood pressure 148/92. Cholesterol "managed" on a statin. He had slowed down. He had resigned himself.

His standard file was a page of medications. What was not in it: a single fasting insulin value, a liver panel in the previous three years, an hs-CRP ever, or any question about sleep.

Extended workup:

• Fasting insulin 34 µIU/mL
• HOMA-IR 14
• ALT 71, AST 52
• hs-CRP 6.1
• HbA1c 7.9, fasting glucose 162
• Sleep study: moderate obstructive sleep apnoea, oxygen dipping to 85% multiple times a night

Imran did not have a drug-resistant diabetes. He had a sleep apnoea that was driving his cortisol every night, a fatty liver that was feeding his fasting glucose, and an inflammatory load that was holding his insulin hostage. Three of his drugs were chasing the consequences.

CPAP for the apnoea. Weight training twice a week. A cardiometabolic food pattern. Targeted supplementation for the liver. Statin continued because cardiovascular risk was real.

At twelve months: HbA1c 6.0 on halved metformin alone, BP 126/82 without antihypertensive escalation, ALT 28, hs-CRP 1.3, daytime energy transformed. He now sleeps through the night for the first time in twenty years. That, more than the HbA1c, is what he describes as the change.

The tests most patients never get

If you have been told you are diabetic, prediabetic, or "borderline," ask for - or request from us - a panel that includes:

• Fasting insulin and HOMA-IR
• ALT, AST, and an abdominal ultrasound for fatty liver
• hs-CRP for inflammation
• Triglyceride to HDL ratio
• Vitamin D, B12, and ferritin
• A thorough sleep history and, if suspected, a sleep study
• A gut history: antibiotics, PPI use, bowel patterns, reflux

This is not an exotic list. It is the panel that changes the story from "your sugar is high" to "here is why your sugar is high."

What remission actually looks like

Remission is not a single moment on a report. It is a pattern over eighteen to twenty-four months:

• HbA1c stable in the non-diabetic range
• Fasting insulin below 10, HOMA-IR below 2
• Medication dose decreasing, not increasing
• Liver enzymes and ultrasound normalising
• Inflammation markers falling
• Energy, sleep, and cognition improving as the biology repairs

When the drivers are addressed, the pancreas rests, the liver empties, the gut heals, and the sugar number moves by itself. The sugar is no longer the target. It is the result.

Two honest cautions

Medication is not the enemy. In early treatment, medication often buys the body safety while you do the real work. Stopping a drug without a clinical plan can be dangerous, especially in patients with longer disease duration or with insulin on board. Every taper we do is clinically supervised. Your medication plan is between you and your treating doctor.

Not every diabetes is reversible. Long-duration Type 2 diabetes, especially when beta-cell reserve is exhausted, may not fully remit. That is an honest clinical reality. But almost every case can improve - lower doses, fewer complications, better quality of life - when the drivers are addressed. "Not fully reversible" is not the same as "nothing to do."

Why this matters for India specifically

Indians develop Type 2 diabetes at lower BMI, at younger ages, with more fatty liver, and with earlier insulin resistance than their Western counterparts. The "cut sugar, walk more" script is a particularly poor fit for an Indian body that is often thin-outside-fat-inside, vitamin-D-depleted, sleep-deprived, and running on a gut that has seen too many antibiotics. Treating Indian diabetes as a sugar problem is a category error. It is, and has always been, a metabolic, hepatic, gut, and circadian problem - with sugar as the final symptom.

What to do next

If you have been recently diagnosed - do not accept "lifestyle disease, cut sugar, take metformin" as the entire plan. Ask for the full panel. Ask why the sugar is high, not just that it is high.

If you have been diabetic for years and your dose only goes up - the sugar number is not going to move until the drivers are addressed. Adding a fourth drug is not a treatment plan. It is a surrender.

Your diabetes deserves answers, not just a prescription.